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Background: Mosquitoes are becoming increasingly resistant to the chemical insecticides currently available for
malaria vector control, spurring interest in alternative management tools. One promising technology is the use of
fungal entomopathogens. Fungi have been shown to impact the potential for mosquitoes to transmit malaria by
reducing mosquito longevity and altering behaviour associated with flight and host location. Additionally, fungi
could impact the development of malaria parasites within the mosquito via competition for resources or effects
on the mosquito immune system. This study evaluated whether co-infection or superinfection with the fungal
entomopathogen Beauveria bassiana affected malaria infection progress in Anopheles stephensi mosquitoes.
Methods: The study used two parasite species to examine possible effects of fungal infection at different parasite
development stages. First, the rodent malaria model Plasmodium yoelii was used to explore interactions at the
oocyst stage. Plasmodium yoelii produces high oocyst densities in infected mosquitoes and thus was expected to
maximize host immunological and resource demands. Second, fungal interactions with mature sporozoites were
evaluated by infecting mosquitoes with the human malaria species Plasmodium falciparum, which is highly efficient
at invading mosquito salivary glands.
Results: With P. yoelii, there was no evidence that fungal co-infection (on the same day as the blood meal) or
superinfection (during a subsequent gonotrophic cycle after parasite infection) affected the proportion of mosquitoes
with oocysts, the number of oocysts per infected mosquito or the number of sporozoites per oocyst. Similarly, for
P. falciparum, there was no evidence that fungal infection affected sporozoite prevalence. Furthermore, there was
no impact of infection with either malaria species on fungal virulence as measured by mosquito survival time.
Conclusions: These results suggest that the impact of fungus on malaria control potential is limited to the
well-established effects on mosquito survival and transmission behaviour. Direct or indirect interactions between
fungus and malaria parasites within mosquitoes appear to have little additional influence.
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Malaria vector control programmes are currently being
threatened by increasing insecticide resistance in adult
mosquito populations [1-4]. This has spurred interest in
the development of alternative management tools, includ-
ing the use of entomopathogenic fungi [5-8]. Fungal
spores infect mosquitoes on contact and can be integrated
into a number of delivery systems, including wall treat-
ments [7,9-11], eave nets and curtains [8], baited traps
[12], and point source targets [8,13,14]. Conidial storage* Correspondence: yxh5118@psu.edu
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article, unless otherwise stated.and persistence characteristics are competitive with those
of commonly-used chemical insecticides [10]. Importantly,
fungi are effective against existing insecticide-resistant
mosquito populations [6,7,15] and are expected to impose
reduced selection for new resistance traits relative to
conventional chemicals [16-19].
Chemical insecticides generally kill or knock down sus-
ceptible mosquitoes within hours of exposure [20]. In con-
trast, fungal biopesticides are relatively slow-acting, taking
up to a week or more to kill exposed mosquitoes [5,13].
This slower action can still be sufficient to block malaria
transmission, since mosquitoes do not become infective
until the end of the malarial extrinsic incubation periodCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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causes a number of sublethal effects (e.g., decreased host
location ability [21] and feeding propensity [7,11,22,23])
that further reduce the probability of disease transmission.
One early study found that the combination of high
mortality and low sporozoite rates associated with Beau-
veria bassiana fungal infection significantly reduced the
number of Anopheles stephensi mosquitoes that both
survived to the end of the EIP and were potentially able to
transmit Plasmodium chabaudi malaria [5]. The authors
also noted that mosquitoes co-infected with fungus and
malaria exhibited an upward trend in daily mortality
rate toward the end of the EIP that was not evident in
mosquitoes infected with either malaria or fungus alone
[5]. However, there has been negligible follow-up work
to validate this preliminary observation. If either co-
infection (i.e., mosquitoes infected with fungus and
malaria parasites at more or less the same time during
the same gonotrophic cycle) or superinfection (i.e., mos-
quitoes encountering the fungus during a later gono-
trophic cycle when the malaria parasite is already
established) alter the development of either the fungus
or malaria parasite, there could be important implica-
tions for malaria control. For example, if fungal infection
directly or indirectly inhibited sporozoite invasion of the
salivary glands, control programmes could potentially use
fungal strains that were less virulent to mosquitoes, which
would in turn reduce selection for resistance in vector
populations [16-19].
The effects of co- and superinfection are highly variable
in other mosquito-pathogen systems. The fungal entomo-
pathogens Metarhizium anisopliae and B. bassiana can
inhibit dengue virus replication and dissemination in
co-infected Aedes aegypti mosquitoes [24,25]. Infection
with certain species of Wolbachia bacteria also can
inhibit establishment of other bacterial [26], nematode
[26] and viral [27-32] superinfections. The impacts of
Wolbachia infection on malaria parasites have been
mixed, with reductions in oocyst densities occurring
under some conditions [33-35] and enhancement observed
under others [36,37]. The mechanisms underlying these
phenotypes remain unresolved but appear to be mediated
by resource competition [38] and/or upregulation of im-
mune factors [24,27,28,34,35,39,40].
Similar mechanisms could affect interactions between
fungal pathogens and malaria parasites. The mosquito
responds to the early ookinete stages of malaria infection
by upregulating immune responses including melaniza-
tion [41] and the Toll pathway or, in the case of human
malaria species, the IMD pathway [42-44]. There is
evidence that malaria parasites utilize host resources as
sporozoites replicate within the oocysts [45], and resource
depletion might increase host susceptibility to secondary
infection. During the final stage of infection, sporozoitesare actively degraded in the haemocoel [46], potentially ei-
ther reducing (via depletion) or enhancing (via upregu-
lation) the availability of haemocytes to combat
additional infectious agents. Fungal infection itself trig-
gers a number of similar immune responses in insect
hosts. Early fungal invasion of the haemocoel is coun-
tered by cellular immune responses [47], which can re-
sult in granulocyte depletion as the infection progresses
[48]. Later in the infection, immune factors involved in
the humoral melanization response [47,49] and the Toll
and JAK-STAT pathways [24] are involved in counter-
ing fungal proliferation. Thus, depending on the timing
of the malaria and fungal infections, there might be
extensive overlap in immune and resource demands on
the mosquito host.
This study explored whether co- or superinfection with
a candidate strain of the fungal entomopathogen B. bassi-
ana affected a number of malaria infection parameters.
Two different malaria species were used to evaluate
potential interactions at different stages of the malaria life
cycle. To examine impacts at the oocyst stage, A. stephensi
mosquitoes were infected with Plasmodium yoelii, a
rodent malaria species which produces high oocyst dens-
ities in infected mosquitoes [50]. High oocyst intensities
have been found to increase vector mortality rates [51-53]
(but see [54]), so it was expected that any mortality
costs associated with malaria-fungus co-infection would
be maximized in high-intensity infections. The mosqui-
toes were exposed to fungus either immediately following
the blood meal (to simulate co-infection) or three days
later to simulate superinfection during the next gono-
trophic cycle following oocyst establishment. There
were no significant effects of co- or superinfection on
oocyst prevalence, oocyst intensity, sporozoite replication
(represented by the number of sporozoites per oocyst), or
mosquito mortality rate among the various treatment
groups.
To determine whether there were late-stage interactions
between fungal superinfection and malaria sporozoites,
mosquitoes were infected with Plasmodium falciparum, a
human malaria species which produces lower oocyst
densities but is much more efficient at invading mos-
quito salivary glands than P. yoelii [55,56]. Late fungal
infection was simulated by exposing mosquitoes to fun-
gus either eight or 11 days after the infectious blood
meal. Regardless of exposure day, fungal treatment had
no effect on sporozoite prevalence in the salivary glands,
nor did the presence of malaria appear to affect subse-
quent fungal virulence. Overall, the results did not indi-
cate a significant interaction between mosquito, fungus
and parasite, and suggest that interaction with malaria
infection is unlikely to have either positive or negative
consequences for this potential of this fungal biopesticide
to reduce transmission.
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Mosquito rearing
Anopheles stephensi mosquitoes were raised under stand-
ard insectary conditions at 27°C and 75% relative humidity
with a 12-hour light/12-hour dark cycle. Mosquito eggs
were hatched in plastic tubs containing 1.5 l of distilled
water. Four days later, larvae were placed into new tubs
containing 400 individuals per tub and provided with
10 mg of powdered Tetrafin fish flakes (TetraFin, Melle,
Germany) daily. Pupae were placed into cages for emer-
gence, and adults were given a 10% glucose solution
supplemented with 0.05% para-aminobenzoic acid (PABA)
to enhance P. yoelii oocyst infection rate [57].
Conidial production and formulation
Oil suspensions of B. bassiana (isolate I93-825) conidia
were prepared according to established protocols [5,7].
Conidia harvested from potato dextrose agar (Oxoid,
UK) were suspended in sterile 0.05% Tween 80 (Sigma)
at a concentration of 106 conidia/ml. Liquid cultures
containing 1 ml of suspension and 75 ml of sterile liquid
culture medium (4% d-glucose, 2% yeast extract (Oxoid,
UK) in tap water) were incubated on a shaker at 24°C
and 160 rpm for three days then diluted with 75 ml
distilled water. The mixture was used to inoculate sterile
solid medium (1 kg barley flakes (Bobs Red Mill,
Milwaukie, OR, USA) and 600 ml tap water), sealed in
mushroom spawn bags (Unicorn, Garland, TX, USA)
and incubated at 24°C for ten days. The bag contents
were then dried in paper bags to a moisture level
of <20%. Conidia were harvested using a Mycoharvester
(Acis Manufacturing, Devon, UK), dried over silica gel
to a moisture level of 5% and sealed in foil sachets for
storage at 5°C. Prior to the experiment, conidial viability
was assessed by suspending conidia in Isopar M oil and
plating the suspension on Sabouraud dextrose agar
(Oxoid, UK). Three replicate plates were incubated at
25°C for 20 hours, and 300 spores per plate were visually
assessed under a compound microscope to ensure that
more than 85% of conidia had successfully germinated.
A new suspension was prepared by adding dry conidia
to an oil mixture (80% Isopar M:20% Ondina) at a con-
centration of 107 conidia/ml, which was verified using a
hemocytometer. The suspension was then applied to
clay tiles as described below.
Substrate preparation
The conidial suspensions were applied to clay tiles in a
manner designed to simulate spray treatments on clay/
mud walls of traditional African huts [7,10,20]. Tiles
were created by pouring a slurry of white earthenware
clay (Clay King, Spartanburg, SC, USA) and distilled
water into 150 mm petri plates. All tiles were air-dried for
at least one week until they had hardened completely. Thedry tiles were then affixed to the back wall of a fume hood,
and a handheld airbrush sprayer was used to uniformly
apply 20 ml of conidial suspension to a 0.5 sq m area for a
final application rate of 8 × 108 conidia/sq m. At higher
application rates, this fungal isolate kills mosquitoes
within three to five days [7], so this relatively low applica-
tion rate was selected to allow mosquitoes to live long
enough post-infection so that potential interactions with
malaria could be observed. Control tiles were sprayed
with a blank oil formulation, and all tiles were air-dried
overnight.
Plasmodium yoelii assays
The rodent malaria model P. yoelii was used to assess
the impact of fungal co- and superinfection on malaria
oocyst prevalence and intensity. Three- to five-day-old
female mosquitoes were starved overnight then allowed
to feed on female six to eight week-old C57 mice (Charles
River, Malvern, PA, USA) for up to 30 min. Mosquitoes
from the malaria infection treatments were fed on anes-
thetized mice which had been injected with 105 P. yoelii
parasites (yoelii strain, clone 17XNL, WHO Registry of
Standard Malaria Parasites, University of Edinburgh, UK)
four days prior, while mosquitoes from the control treat-
ments were fed on uninfected mice. All blood feeds took
place at 26°C to maximize feeding, and mosquitoes that
were not fully engorged were removed from the experi-
ment. The mosquitoes were then moved to a 24°C incuba-
tor to maximize P. yoelii growth and survival [58].
Following a one-hour acclimation period, the mosqui-
toes were randomly allocated to a number of treatment
groups. Half the mosquitoes were exposed to fungus-
treated or control tiles on the same day as the blood
meal (day 0 exposures). Groups of approximately 50 in-
dividuals were aspirated into standard WHO cones on
tiles and left for a 30-min exposure period. Afterward,
the mosquitoes were aspirated into nylon-covered cups
and placed in a 24°C incubator. Mortality was monitored
daily. The other half of the mosquitoes were aspirated
directly into nylon-covered cups and placed into the
24°C incubator. In this group, delayed fungal exposure
was simulated by exposing the mosquitoes to the tiles
three days after the blood feed, coinciding with when
they would have been expected to seek their next blood
meal (day 3 exposure). Thus, there were four treatment
groups for each of the two exposure time points: dual
infection (fungus and malaria), fungal infection alone,
malaria infection alone and no infection. There were
five replicate cups of approximately 50 mosquitoes per
cup (~250 mosquitoes total) for each treatment and
time point. All cups were held at 24°C and provided
with a cotton ball saturated with glucose-PABA solu-
tion for nutrition. Mosquito mortality was monitored
daily until all mosquitoes in the fungal treatments were
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day 3 exposures).
Seven days after the blood feed, 20 mosquitoes from
each treatment group were dissected and examined for
oocysts. Oocyst prevalence (the proportion of infected
mosquitoes in each treatment) and oocyst intensity (the
number of oocysts in each infected individual) were
recorded, and each midgut was placed in 10 μl of 70%
EtOH and stored at −80°C.
Quantitative PCR was used to estimate the number of
sporozoites per oocyst, a measure of parasite replication
rate. The Microelute Tissue DNA Kit (Omega Bio-tek)
was used to extract and purify the DNA according to the
manufacturer’s instructions with one exception: during
the tissue lysis step, a stainless steel ball was added to each
tube. The samples were then homogenized for 30 sec at
30 Hz on a TissueLyser (Qiagen) prior to being incubated
at 55°C and processed according to the kit protocol. The
purified DNA was eluted in 20 μL of buffer and stored
at −20°C.
Real-time quantitative PCRs were performed using the
Plasmodium primers and probe described by Bell et al.
[59]. Reaction mixtures were prepared by adding 2 μL of
purified DNA template to a reaction mix of 1.5 μL each
of 5 μM dilutions of forward and reverse primers, 1 μL
of 5 μM probe, 12.5 μL of PerfeCTa® qPCR FastMix®
(UNG, Low ROX™ by Quanta BioSciences) and 6.5 μL of
RNAse-free water. The reactions were run on a Prism
7500 Sequence Detection System (TaqMan) with an
initial 20-sec activation step at 95°C followed by 40 cycles
of denaturation at 95°C for 3 sec and annealing/exten-
sion at 60°C for 30 sec. Serial dilutions of P. yoelii DNA
standard spanning five orders of magnitude (7.22 × 104
to 7.22 sporozoites) were used to generate a standard
curve for absolute quantification of the samples. Three
replicates of each standard were included in each reaction
run.
Plasmodium falciparum assays
The human malaria parasite P. falciparum was used to
assess interactions between fungal infection and sporozo-
ites. In vitro gametocyte production followed established
procedures [60]. NF54 strain P. falciparum cultures were
maintained in vitro in O+ erythrocytes in a culture
medium of RPMI 1640 (25 mM HEPES, 2 mM L-glutam-
ine), 50 μM hypoxanthine and 10% A+ serum in an
atmosphere of 5% CO2, 5% O2 and 90% N2. At 5% haem-
atocrit and 0.8-1% parasitaemia (mixed stages), gameto-
cyte cultures were initiated. Media was changed daily, and
the cultures were maintained for up to 17 days. On the
day of the feed, the gametocyte cultures were spun down,
and the pelleted infected erythrocytes were diluted to
2% gametocytaemia and 40% haematocrit with fresh
A+ human serum and O+ erythrocytes.Three- to five-day-old female mosquitoes were aspirated
into replicate cups and allowed to feed on warmed mem-
brane feeders containing either the infectious blood mix-
ture or uninfected blood for up to 30 min. Unfed
mosquitoes were removed from each cup as described
above. Seven days after the blood meal, seven mosquitoes
from each malaria-infected cup were dissected as described
above to ensure that there were no significant differences in
initial oocyst prevalence (mean ± SE 0.44 ± 0.05, Fisher’s
exact test p = 0.116) or intensity (1.52 ± 0.12; Kruskal-
Wallis χ2 = 1.78, df = 3, p = 0.620) among the malaria
treatment groups.
As described in the P. yoelii experiment, the mosquitoes
were exposed to either fungus-treated or control tiles at
two time points following the blood feed, generating four
treatment groups (dual infection, fungal infection alone,
malaria infection alone and no infection) per time point.
However, this experiment simulated late fungal exposure
by exposing the mosquitoes to the tiles either eight or
11 days after the blood feed. The day 11 treatments each
included three replicate cups of approximately 30 mosqui-
toes per cup, and the day 8 treatments each included three
replicate cups of approximately 50 mosquitoes per cup to
ensure that an adequate number survived to the sporozo-
ite stage. All cups were held at 27°C and were supplied
with a cotton ball soaked with glucose-PABA solution,
and daily mortality was monitored for 14 days following
the blood meal. Over the next two days (days 15–16 after
the blood meal), the remaining mosquitoes in the malaria
infection treatments (malaria alone and dual infection)
were dissected, and their salivary glands were inspected
under a microscope for the presence of sporozoites. In
the malaria control treatments (fungus alone and no
infection), daily mortality was monitored until all the
fungus-exposed mosquitoes had died (22 days after
fungal exposure in the day 8 exposures, 20 days in the
day 11 exposures).
Statistical analysis
Median survival times for each treatment group were
calculated using the Kaplan-Meier procedure. The effects
of fungal exposure and malaria infection on mosquito sur-
vival were analysed using a full factorial Cox proportional
hazards model with backward stepwise elimination of
non-significant interactions (p > 0.05). The impacts of fun-
gal exposure and malaria infection on the various malaria
infection parameters were evaluated using generalized
linear models (GLM) with the model error distributions
and link functions adjusted to fit the data. For the P. yoelii
experiments, oocyst prevalence was analysed using a bino-
mial GLM with a logit link function. Oocyst intensity and
the mean number of sporozoites per oocyst were heavily
right-skewed, so treatments were compared using a
negative binomial GLM with a log link function. In the
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lence (the proportion of dissected mosquitoes with sporo-
zoites in their salivary glands) were overdispersed, so
treatment effects were analysed using a quasibinomial
GLM with a logit link function. In each case, the analyses
began with a full factorial model including malaria infec-
tion and fungal exposure as variables. In the P. falciparum
experiments, replicate cup was also included in the initial
model but was not significant. Non-significant variables
(p > 0.05) were then removed from each model using
backward stepwise elimination. All analyses were per-
formed in R [61].
Results
Plasmodium yoelii experiment
Mosquito mortality rate varied with treatment group
(Figure 1) but was not significantly affected by P. yoelii mal-
aria infection status (hazard ratio (HR) = 0.95, z = −0.77,
p = 0.44). Fungal exposure significantly increased mortality
rate (HR = 17.06, z = 21.11, p < 0.001); mosquitoes exposed
to fungus had median survival times of eight to ten days
relative to >25 days in the controls. There was also a
significant interaction between fungal exposure and expos-
ure day (HR = 0.64, z = −3.42, p = 0.001), such that, even
after accounting for the delay in fungal infection, the mos-
quitoes exposed to fungus on day 3 had median survival
times about one day longer than those exposed on the
same day as the blood meal.
None of the P. yoelii malaria infection parameters was
significantly affected by fungal exposure or exposure
timing (Table 1, Figures 2 and 3). Infection prevalence
was slightly higher in the day 0 exposure groups (90% for
both fungus and control mosquitoes) than in the day 3
groups (75% for fungus and 70% for controls), but the dif-
ference was marginally insignificant (z = −1.94, p = 0.053).
Although the number of sporozoites per oocyst was lowerFigure 1 Cumulative proportional survival of adult mosquitoes in the P
fed either on P. yoelii-infected or control mice (indicated by line type), then ex
(indicated by marker) either the same day as the blood meal (d0) or three da
five replicates (± standard error).in mosquitoes exposed to fungus (z = 2.15, p = 0.032),
this result was driven by a single outlier. When this
data point was not included in the analysis, neither
fungal exposure (χ2 = 1.22, p = 0.269) nor exposure timing
(χ2 = 1.06, p = 0.303) significantly affected sporozoite dens-
ity per oocyst.
Plasmodium falciparum experiment
There was no evidence that mosquito survival to the
infectious stage (14 days after the blood feed) was af-
fected by P. falciparum infection (HR = 1.02, z = 0.14,
p = 0.888). There was a significant interaction between
fungal exposure and exposure day (HR = 5.57, z = 2.90,
p = 0.004), but this was likely due to the timing of the
dissections. Mosquito survival is generally quite high in
the first few days of fungal infection because the fungus
requires time to develop and invade the haemocoel [47].
Once the infection is established, however, mosquito sur-
vival plummets rapidly. Mosquitoes in the day 11 malaria
treatments were dissected just three days after fungal
exposure when very few mosquitoes had died (≤14% in all
treatments, Figure 4). In contrast, mosquitoes in the day 8
treatments were dissected six days after fungal exposure,
at which point mosquito mortality was much higher in
the fungal treatment groups (>40%) than the controls
(<10%). When only the first three days following exposure
were evaluated in all the treatments, neither exposure day
(HR = 0.98, z = −0.06, p = 0.95) nor fungal exposure (HR =
1.14, z = 0.34, p = 0.71 significantly influenced mortality.
There was also no evidence that exposure day significantly
affected mortality rate in the malaria control treatments
(HR = 1.21, z = 1.79, p = 0.074), which were monitored for
up to 22 days after fungal exposure (Figure 4 insert).
Although fewer mosquitoes in the day 8 fungal exposure
treatments survived to the end of the EIP, sporozoite
prevalence (the proportion of mosquitoes with sporozoiteslasmodium yoelii experiment. Anopheles stephensi mosquitoes were
posed to tiles sprayed with B. bassiana conidial suspensions or blank oil
ys later (d3, indicated by line colour). Each point represents the mean of







Oocyst intensity Sporozoites per oocyst (×103)
N Mean ± SE Median N Mean ± SE Median
Day 0 Fungus 0.9 18 31.72 ± 9.93 8.5 17 11.44 ± 5.01 5.93
Control 0.9 18 40.67 ± 7.07 47 18 6.38 ± 1.10 5.60
Day 3 Fungus 0.75 15 38.33 ± 14.05 14 14 10.10 ± 3.67 5.71
Control 0.7 14 24.29 ± 9.07 11 14 6.35 ± 1.12 6.06
Oocyst prevalence represents the proportion of An. stephensi mosquitoes with ≥1 oocyst in a sample of n = 20 mosquitoes per treatment. Of the infected
mosquitoes (N), we report the mean (± standard error) and median estimates for oocyst intensity and number of sporozoites per oocyst. The sample number
decreases slightly in the sporozoite per oocyst because the PCR failed for some of the midgut samples.
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groups (Table 2). There was no evidence that sporozoite
prevalence in the surviving mosquitoes was affected
by either fungal exposure (F = 0.25, df = 1, p = 0.614)
or exposure day (F = 0.37, df = 1, p = 0.544).
Discussion
This study found no significant evidence that B. bassi-
ana exposure affected malarial parasite development.
With P. yoelii, there was no evidence that fungal co- or
superinfection affected oocyst prevalence, oocyst inten-
sity or the number of sporozoites per oocyst. Similarly,
with P. falciparum, there was no evidence of an effect of
fungal superinfection on sporozoite prevalence in surviv-
ing mosquitoes. Furthermore, there was no evidence in
either experiment that malaria infection affected overall
fungal virulence as measured by mosquito survival time.
Due to experimental constraints, many of the analyses
associated with malaria infection parameters were based
on small sample sizes. However, assuming α = 0.05 and
β = 0.2, all of the analyses would have been expected to
detect proportional differences of ≥0.8 except for theFigure 2 Plasmodium yoelii oocyst intensity (number of oocysts
per midgut). Boxes represent the first and third quartiles, and whiskers
encompass the values within 1.5 interquartile ranges of the lower and
upper quartiles.day 3 oocyst intensity assay (see Additional file 1). Al-
though many of the analyses would have been insensitive
to smaller impacts, low-level variation in malaria infec-
tion intensity or prevalence would likely be of limited
importance in the context of transmission control. Mos-
quitoes with very few oocysts still become infectious,
and the majority of mosquitoes that encountered fungus
early in the malarial extrinsic incubation period (EIP)
would not be expected to survive long enough to infect
new hosts, particularly if higher fungal application rates
were used [7]. For mosquitoes exposed late in the EIP,
small reductions in sporozoite prevalence would likely
have little impact on disease burden, particularly in high
transmission areas where hosts may receive hundreds of
infectious bites per year [62-64].
The results of this study generally support those of
Blanford et al. [5], who performed an experiment similar
to the day 0 P. yoelii experiment using a different species
of malaria (P. chabaudi) but the same mosquito species
and fungal strain. At the oocyst stage, neither study
found evidence of an impact of fungal co-infection on
oocyst prevalence or density. At the sporozoite stage,Figure 3 Number of Plasmodium yoelii sporozoites per oocyst
(103) by treatment. Boxes represent the first and third quartiles,
and whiskers encompass the values within 1.5 interquartile ranges
of the lower and upper quartiles.
Figure 4 Cumulative proportional survival of adult mosquitoes in the Plasmodium falciparum experiment. Anopheles stephensi mosquitoes
were fed on control mice, then exposed to tiles sprayed with B. bassiana conidial suspensions (‘fungus’) or blank oil (indicated by marker) either eight
(d8) or 11 days later (d11, indicated by line colour). Each point represents the mean of three replicates (± standard error). (Inset) Proportional survival
(y-axis) of malaria control treatments (B. bassiana fungus only and no infection groups) through day 20 following fungal exposure (x-axis).
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cantly decreased the proportion of the initial (day 0)
population which was both alive and infectious 14 days
later. The sporozoite experiments in the current study
differed from those in Blanford et al. [5] in two ways:
sporozoite prevalence was evaluated in mosquitoes ex-
posed to fungus late in the EIP (day 8 or day 11) and the
lethal and non-lethal effects of fungal exposure were
analysed separately. These analyses showed that, while
fungal infection did significantly reduce mosquito survival
in the day 8 exposures, there was no evidence of add-
itional variation in sporozoite prevalence in the surviving
population (i.e., those mosquitoes which were alive at the
end of the EIP) for either exposure day. Given that there
was also no evidence that malaria interacted with fungus
to affect mosquito survival, these results suggest that the
reductions in infectious mosquitoes in the late-exposure
experiments were primarily mediated by mortality due to
fungal infection rather than by interactions between
P. falciparum and fungus.
Blanford et al. [5] did note an upward trend in daily
mortality rate in mosquitoes co-infected with fungus
and malaria around the sporozoite release stage which
was absent in the treatment groups infected with fungusTable 2 Summary of Plasmodium falciparum sporozoite
prevalence
Exposure day Fungal treatment Proportion infectious (N)
Day 8 Fungus 0.28 (39)
Control 0.32 (84)
Day 11 Fungus 0.33 (43)
Control 0.38 (34)
The proportion infectious An. stephensi mosquitoes is equal to the number of
mosquitoes with successful sporozoite invasion of the salivary glands divided
by the total number of mosquitoes dissected (N).alone. The current study also found an apparent increase
in daily mortality rate in the P. yoelii experiment starting
at approximately day 12 in the ‘day 0 co-infection’ treat-
ment relative to the ‘day 0 fungus alone’ treatment (see
Additional file 2). However, the pattern was reversed in
the equivalent super-infection treatments, with the ‘day
3 fungus alone’ treatment showing an increase in late
stage daily mortality whereas the ‘day 3 superinfection’
treatment did not. Unfortunately, the very small sample
sizes at the late stage of fungal infection make it difficult
to interpret these patterns with great confidence, since
differences of just one or two survivors would have led
to large differences in proportional mortality.
The current study also agrees with a study by Fang
et al. [65] using a different mosquito-fungus combination
(Anopheles gambiae and M. anisopliae). That group
reported no effect of late superinfection on ultimate
prevalence or density of P. falciparum sporozoites in the
salivary glands. These consistent results across different
species and application methods suggest that the lack of
interaction between fungal and malarial infections may
be a general phenomenon among common fungal ento-
mopathogens, though these dynamics can be altered via
genetic modification [65].
Although malaria infection did not affect overall fungal
virulence, mosquitoes exposed to fungus on the same
day as the blood meal died marginally more quickly than
those exposed three days later. Blood feeding greatly alters
female physiology [66], and previous work has shown that
there could be trade-offs between immune response and
reproduction in mosquitoes [67]. Similar trade-offs could
explain why mosquitoes might be more susceptible to fun-
gal infection when they are actively digesting a blood meal.
However, there is also evidence that blood feeding can
temporarily increase resistance to fungal infection in
An. gambiae and Aedes aegypti relative to individuals fed
Heinig and Thomas Malaria Journal  (2015) 14:22 Page 8 of 10exclusively on glucose [68,69], though no such increase
was observed in An. stephensi [7].
There are a number of additional factors that could influ-
ence mosquito-malaria-fungus interactions. For example,
hydric and nutritional stress can increase mosquito mor-
tality associated with malaria infection [51,53,70,71], and
restricted diets are associated with a decrease in the
mosquito melanization response [72]. The mosquitoes
in this experiment were well-fed with easy access to
sugar sources, potentially obscuring any resource compe-
tition or energetic tradeoffs involved in mounting an
immune response that might occur under less favourable
nutritional conditions. There is also natural variation
between and among mosquito species to malaria infection
[73,74], and the potential for complex effects of environ-
mental variables, such as temperature, on mosquito im-
mune function [75-77]. It is possible, therefore, that more
diverse mosquito-parasite-pathogen interactions could be
revealed under different contexts.
Conclusion
Overall there was little evidence for impacts of the fungal
pathogen, B. bassiana, on infections of either rodent or
human malaria within the mosquito host or for any recip-
rocal effects of malaria infection on fungal virulence. These
results suggest that, compared to factors such as biopesti-
cide coverage, dose and substrate [7,10], malaria-fungus
interactions will have a relatively small impact on the
potential of this fungus to reduce malaria transmission.
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